Studien

ACTG 5090

AIDS Clinical Trials Group 5090

ACTG 5093

AIDS Clinical Trials Group 5093

ACTG 5095

AIDS Clinical Trials Group 5095

ACTG 5114

AIDS Clinical Trials Group 5114

ACTG 5125s

AIDS Clinical Trials Group 5125s

ACTG 5142

AIDS Clinical Trials Group 5142

ACTG 5143

AIDS Clinical Trials Group 5143

ACTG 5146

AIDS Clinical Trials Group 5146

ACTG 5152s Stein

AIDS Clinical Trials Group A5152s Stein

ACTG 5157

AIDS Clinical Trials Group 5157

ACTG 5164

AIDS Clinical Trials Group 5164

ACTG 5170

AIDS Clinical Trials Group 5170

ACTG 5188

AIDS Clinical Trials Group 5188

ACTG 5206

AIDS Clinical Trials Group 5206

ACTG 5214

AIDS Clinical Trials Group 5214

ACTG 5220

AIDS Clinical Trials Group 5220

ACTG 5229

AIDS Clinical Trials Group 5229

ACTG 5312

High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis

ACTG 5343

Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis

ACTG 700

AIDS Clinical Trials Group 700

ACTG 709

AIDS Clinical Trials Group 709

ACTG 731

AIDS Clinical Trials Group 731

ACTG 892

AIDS Clinical Trials Group 892

ACTG 981

AIDS Clinical Trials Group 981

ACTG A328

AIDS Clinical Trials Group A328

ACTG A5001/ALLRT

AIDS Clinical Trials Group A5001/ALLRT

ACTG A5024

AIDS Clinical Trials Group A5024

ACTG A5030

AIDS Clinical Trials Group A5030

ACTG A5031s

AIDS Clinical Trials Group A5031s

ACTG A5043

AIDS Clinical Trials Group A5043

ACTG A5047

AIDS Clinical Trials Group A5047

ACTG A5051

AIDS Clinical Trials Group 5051

ACTG A5071

AIDS Clinical Trials Group A5071

ACTG A5073

AIDS Clinical Trials Group A5073

ACTG A5078

AIDS Clinical Trials Group A5078

ACTG A5084

AIDS Clinical Trials Group A5084

ACTG A5086

AIDS Clinical Trials Group A5086

ACTG A5090

AIDS Clinical Trials Group A5090

ACTG A5092s

AIDS Clinical Trials Group A5092s

ACTG A5093

AIDS Clinical Trials Group A5093

ACTG A5095

AIDS Clinical Trials Group A5095

ACTG A5097s

AIDS Clinical Trials Group A5097s

ACTG A5102

AIDS Clinical Trials Group A5102

ACTG A5108

AIDS Clinical Trials Group A5108

ACTG A5110

AIDS Clinical Trials Group A5110

ACTG A5114

AIDS Clinical Trials Group A5114

ACTG A5117

AIDS Clinical Trials Group A5117

ACTG A5127

AIDS Clinical Trials Group A5127

ACTG A5142

AIDS Clinical Trials Group A5142

ACTG A5143

AIDS Clinical Trials Group A5143

ACTG A5150

AIDS Clinical Trials Group A5150

ACTG A5160

AIDS Clinical Trials Group A5160

ACTG A5164

AIDS Clinical Trials Group A5164

ACTG A5166s

AIDS Clinical Trials Group A5166s

ACTG A5170

AIDS Clinical Trials Group A5170

ACTG A5174

AIDS Clinical Trials Group A5174

ACTG A5175 PEARLS

AIDS Clinical Trials Group A5175 PEARLS

ACTG A5177

AIDS Clinical Trials Group A5177

ACTG A5178

AIDS Clinical Trials Group A5178

ACTG A5186

AIDS Clinical Trials Group A5186
Vorherige Seite Nächste Seite
© Der Arzneimittelbrief 2026